HOUSTON and LONDON, March 20, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Thursday a major, multi-year fully integrated completions systems contract with Petrobras. The award followed an open tender and will leverage Baker Hughes' innovative completions technology portfolio and extensive experience in Brazil to optimize production across multiple deepwater fields.

Closed on $65.1 Million of Acquisitions during the First Quarter of 2025 Closed on $65.1 Million of Acquisitions during the First Quarter of 2025

$7.3 million in total neffy ® (epinephrine nasal spray) U.S. net product revenue in 2024 since launch in late September 2024

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: STSS) (the “Company” or “Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company's proposal before the shareholder meeting, which is scheduled to be held on March 28, 2025, at 10:00 a.m. Eastern Time.

NAPLES, Fla. , March 20, 2025 /PRNewswire/ -- Beasley Broadcast Group, Inc. (Nasdaq: BBGI) ("Beasley" or the "Company"), a multi-platform media company, today announced operating results for the three months and year ended December 31, 2024.

CHARLOTTE, N.C. , March 20, 2025 /PRNewswire/ -- The Cato Corporation (NYSE: CATO) today reported a net loss of ($14.1) million or ($0.74) per diluted share for the fourth quarter ended February 1, 2025, compared to a net loss of ($23.4) million or ($1.14) per diluted share for the fourth quarter ended February 3, 2024.

AUCATZYL® (obecabtagene autoleucel) U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024 Obe-cel MHRA and EMA marketing authorizations expected in H2 2025 Initial six patients dosed in Phase 1 dose confirmation trial in Systemic Lupus Erythematosus (SLE) Company to provide clinical development program updates, including plans for expansion in autoimmune diseases, at R&D investor event to be held on April 23rd Conference call to be held today at 08:30 am EDT/12:30 pm GMT: conference call participants should pre-register using the link at the bottom of …

Industry veteran brings extensive oncology drug development expertise and experience in clinical treatment of cancer patients Dr. Matushansky joins as Immuneering plans to present updated data from Phase 2a trial of IMM-1-104 in pancreatic cancer in Q2 2025 CAMBRIDGE, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Immuneering (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced that Igor Matushansky, MD, PhD, has joined the company as Chief Medical Officer.

CHICAGO and LONDON , March 20, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch a second BrokerTec central limit order book (CLOB) for cash U.S. Treasuries in Q3 2025. In an industry-first, the new CLOB will be co-located in Chicago next to CME Group's deeply liquid U.S. Treasury futures and options markets to support trading between cash and derivatives markets.

ATLANTA, March 20, 2025 (GLOBE NEWSWIRE) -- SweetWater Brewing Company ("SweetWater Brewing" or "SweetWater"), the largest craft brewer in Georgia and the Southeast and a Tilray Brands, Inc., company (NASDAQ: TLRY and TSX: TLRY), announces the third year of its partnership with Georgia Aquarium by releasing a limited-edition aquarium-themed version of SweetWater's OG IPA. This collaboration highlights the shared commitment of both organizations to environmental conservation and community engagement.

Leading international boat builder group honors Garmin marine for outstanding service and support for second year in a row OLATHE, Kan. , March 20, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN), the world's most innovative and recognized marine electronics manufacturer, today announced it was awarded the prestigious Supplier of the Year distinction by Independent Boat Builders, Inc. (IBBI).

TORONTO and GLIL YAM, Israel , March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2024 ended December 31, 2024, on Monday, March 31, 2025 before the market opens. The Company will host a zoom web conference on the same day at 9:00a.m.

Announces Intent to Nominate Two Highly Qualified Director Candidates With Lending Experience to Replace CEO Raul Vasquez and Lead Director R. Neil Williams Criticizes Inexperienced Legacy Board Members for Standing in the Way of Significant Shareholder Value Creation Believes Oportun Is Significantly Undervalued NEW YORK , March 20, 2025 /PRNewswire/ -- Findell Capital Management LLC ("Findell"), which beneficially owns approximately 9.1% of the outstanding common stock of Oportun Financial Corporation ("Oportun" or the "Company"), today issued an open letter to the board of directors ("Board") and shareholders of Oportun (NASDAQ: OPRT) laying out the case for change to the leadership …

TORONTO , March 20, 2025 /PRNewswire/ - SolarBank Corporation (NASDAQ: SUUN) )Cboe CA: SUNN) (FSE: GY2) ("SolarBank" or the "Company") is ‎pleased to announce that it has received approval from the New York State Energy Research and Development Authority ("NYSERDA") for $1,058,616 USD in incentives for the 3.26 MW Camillus Solar Project (the "Project") under the NY-Sun Program. As disclosed on March 19, 2025 , the Project has been sold to, and will now be constructed for, Solar Advocate Development LLC (the "Owner") in a transaction valued at $7.3 million USD.

TECELRA® launch momentum accelerating – 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals achieved Lete-cel on track to initiate rolling BLA submission late 2025; approval anticipated 2026 Corporate restructure completed in February 2025 and implementing additional cost reduction for PRAME and CD70 programs At the end of 2024, Adaptimmune had Total Liquidity 1 of $152 million Evaluating all strategic options to maximize shareholder value Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - March 20, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers …

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Crocs, Inc. ("Crocs" or "the Company") (NASDAQ:CROX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Crocs securities between November 3, 2022 and October 28, 2024, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TELUS International (Cda) Inc. ("TELUS" or "the Company") (NYSE:TIXT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TELUS securities between February 16, 2023 and August 1, 2024, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Target Corporation ("Target" or "the Company") (NYSE:TGT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Target securities between March 9, 2022 and November 19, 2024, both dates inclusive (the "Class Period").

KITCHENER, ON , March 20, 2025 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, which is part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar"), has signed a Battery Supply Agreement and Long-Term Service Agreement (LTSA) with Strata Clean Energy's White Tank Energy Storage LLC for a 100 MW / 576 MWh DC Battery Energy Storage System (BESS) in Arizona, USA.

Altair's technology and JetZero's unique blended wing airplane unite to reshape the future of aviation TROY, Mich. , March 20, 2025 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational intelligence, and JetZero, a company dedicated to developing the world's first commercial blended wing airplane, have joined forces to drive next-generation aerospace innovation.